Health
Moffitt researchers discover regulatory pathway that blocks immune response against cancer – EurekAlert
In a new article published in the journal Immunity, Moffitt Cancer Center researchers show that TIM-3 inhibits the STING signaling pathway in dendritic cells, thereby…
TAMPA, Fla. – A hallmark of cancer is its ability to evade the immune system. It is why researchers are focused on finding new strategies and targets to jumpstart the immune system so it can mount a response against tumors. One such target is the inhibitory receptor T-cell immunoglobulin and mucin domain 3 (TIM-3), a protein that is overexpressed in many different types of cancer and is associated with poor patient outcomes. It is known to block the activity of immune cells, such as dendritic cells,…
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General22 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
Noosa News18 hours agoThe Best Things to Do in Brisbane This New Year’s Eve